# Evaluation of S-600918 in Adults With Refractory Chronic Cough

> **NCT04110054** · PHASE2 · COMPLETED · sponsor: **Shionogi** · enrollment: 406 (actual)

## Conditions studied

- Chronic Cough

## Interventions

- **DRUG:** S-600918
- **DRUG:** Placebo to S-600918

## Key facts

- **NCT ID:** NCT04110054
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2020-12-08
- **Final completion:** 2020-12-28
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110054, "Evaluation of S-600918 in Adults With Refractory Chronic Cough". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04110054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
